244 related articles for article (PubMed ID: 21879340)
21. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
Bossart S; Gabutti MP; Seyed Jafari SM; Hunger RE
Dermatol Ther; 2020 Jul; 33(4):e13771. PubMed ID: 32500585
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program.
Gichane MW; Calo WA; McCarthy SH; Walmer KA; Boggan JC; Brewer NT
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):96-101. PubMed ID: 27498340
[TBL] [Abstract][Full Text] [Related]
23. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Vaccine Uptake After a Tailored, Online Educational Intervention for Female University Students: A Randomized Controlled Trial.
Bennett AT; Patel DA; Carlos RC; Zochowski MK; Pennewell SM; Chi AM; Dalton VK
J Womens Health (Larchmt); 2015 Nov; 24(11):950-7. PubMed ID: 26488269
[TBL] [Abstract][Full Text] [Related]
25. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
[TBL] [Abstract][Full Text] [Related]
26. Understanding human papillomavirus vaccination intentions: comparative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men.
Fisher WA; Kohut T; Salisbury CM; Salvadori MI
J Sex Med; 2013 Oct; 10(10):2455-64. PubMed ID: 23745833
[TBL] [Abstract][Full Text] [Related]
27. The Silver Lining of Shame: Framing HPV to Influence Vaccination Intentions.
Yang JZ; Pittman MM
Health Commun; 2017 Aug; 32(8):987-994. PubMed ID: 27463558
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and genital cancer.
Rapose A
Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
[TBL] [Abstract][Full Text] [Related]
29. Start early to prevent genital HPV infection-and cervical cancer.
Heavey E
Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
[No Abstract] [Full Text] [Related]
30. Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicenter national survey in China.
Zhang SK; Pan XF; Wang SM; Yang CX; Gao XH; Wang ZZ; Li M; Ren ZF; Zhao FH; Qiao YL
Vaccine; 2013 Jul; 31(32):3244-9. PubMed ID: 23707446
[TBL] [Abstract][Full Text] [Related]
31. HPV vaccines: their pathology-based discovery, benefits, and adverse effects.
Nicol AF; de Andrade CV; Russomano FB; Rodrigues LS; Oliveira NS; Provance DW; Nuovo GJ
Ann Diagn Pathol; 2015 Dec; 19(6):418-22. PubMed ID: 26321154
[TBL] [Abstract][Full Text] [Related]
32. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
Westra TA; Stirbu-Wagner I; Dorsman S; Tutuhatunewa ED; de Vrij EL; Nijman HW; Daemen T; Wilschut JC; Postma MJ
BMC Infect Dis; 2013 Feb; 13():75. PubMed ID: 23390964
[TBL] [Abstract][Full Text] [Related]
33. Educational interventions to increase HPV vaccination acceptance: a systematic review.
Fu LY; Bonhomme LA; Cooper SC; Joseph JG; Zimet GD
Vaccine; 2014 Apr; 32(17):1901-20. PubMed ID: 24530401
[TBL] [Abstract][Full Text] [Related]
34. HPV vaccine acceptance among adolescent males and their parents in two suburban pediatric practices.
Khurana S; Sipsma HL; Caskey RN
Vaccine; 2015 Mar; 33(13):1620-4. PubMed ID: 25659275
[TBL] [Abstract][Full Text] [Related]
35. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study.
Coskuner ER; Ozkan TA; Karakose A; Dillioglugil O; Cevik I
J Sex Med; 2014 Nov; 11(11):2785-91. PubMed ID: 25124237
[TBL] [Abstract][Full Text] [Related]
36. A study on the predictors of Korean male students' intention to receive human papillomavirus vaccination.
Choi JS; Park S
J Clin Nurs; 2016 Nov; 25(21-22):3354-3362. PubMed ID: 27378054
[TBL] [Abstract][Full Text] [Related]
37. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women.
Sperber NR; Brewer NT; Smith JS
Cancer Causes Control; 2008 Feb; 19(1):115-8. PubMed ID: 17952620
[TBL] [Abstract][Full Text] [Related]
38. Determinants of HPV vaccine uptake intentions in Chinese clinical interns: an extended theory of planned behavior approach.
Wang H; Xu Y; Zhang H; Chen N
Front Public Health; 2024; 12():1345530. PubMed ID: 38435300
[TBL] [Abstract][Full Text] [Related]
39. The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting.
Sharma M; Sy S; Kim JJ
BJOG; 2016 May; 123(6):917-26. PubMed ID: 26176301
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country.
Dany M; Chidiac A; Nassar AH
Vaccine; 2015 Feb; 33(8):1001-7. PubMed ID: 25597945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
